Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-06-113040
Filing Date
2006-05-16
Accepted
2006-05-15 17:58:29
Documents
5
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K, AMENDMENT d10ka.htm 10-K/A 2292049
2 CERTIFICATION dex311.htm EX-31.1 7282
3 CERTIFICATION dex312.htm EX-31.2 7256
4 CERTIFICATION dex321.htm EX-32.1 3545
5 CERTIFICATION dex322.htm EX-32.2 3444
  Complete submission text file 0001193125-06-113040.txt   2314961
Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 8138642562
ACCENTIA BIOPHARMACEUTICALS INC (Filer) CIK: 0001310094 (see all company filings)

EIN.: 000000000
Type: 10-K/A | Act: 34 | File No.: 000-51383 | Film No.: 06843263
SIC: 2834 Pharmaceutical Preparations